跳至主要内容
临床试验/ISRCTN90702227
ISRCTN90702227进行中(未招募)1 期

Phase I trial: Ocular Technology Group International[The full scientific title will be published within 30 months after the end of the trial]

CooperVision International Limited0 个研究点目标入组 20 人开始时间: 2023年8月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

排除标准

  • The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.

研究者

相似试验

进行中(未招募)
1 期
Phase I trial: Ocular Technology Group International CV23-08The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.
ISRCTN66819383CooperVision International Ltd40
招募中
1 期
ROH-001 ophthalmic solution phase I clinical trial -Single and multiple dose studyHealthy volunteer
JPRN-jRCT2051230128Mantani Tomomi48
进行中(未招募)
1 期
A Phase II, pilot clinical trial to evaluate the effects of atorvastatin on Graves' Orbitopathy (GO) in hypercholesterolemic patients with moderate-to-severe and active GO subjected to intravenous glucocorticoid therapy.Graves’ orbitopathy is a disabling and disfiguring disease affecting the eyes observed in approximately 25-30% of patients with Graves’ disease. Its clinical manifestations include exophthalmos, inflammatory signs and symptoms, diplopia, and in most severe cases sight impairment.MedDRA version: 20.0Level: PTClassification code 10004161Term: Basedow's diseaseSystem Organ Class: 10014698 - Endocrine disorders
EUCTR2018-001317-33-ITAZIENDA OSPEDALIERO-UNIVERSITARIA PISANA88
已完成
不适用
Retinal Artery Study in participants with obstructive sleep apnoea treated with continuous positive airway pressureEndothelial functionSleep ApnoeaCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemRespiratory - Sleep apnoea
ACTRN12610000311055Austin Health Department of Cardiology and Institute for Breathing and Sleep30
已完成
不适用
Eye movement desensitization and reprocessing therapy as video-conference psychotherapyA memory of an adverse life event that causes a disturbing memory trace measured by Subjective Unit of Distress (SUD)Mental and Behavioural Disorders
ISRCTN12099530niversity of Worcester24
Phase I trial: Ocular Technology Group International | 临床试验